Jack D. Bui

7.6k total citations · 1 hit paper
81 papers, 4.2k citations indexed

About

Jack D. Bui is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jack D. Bui has authored 81 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Immunology, 29 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Jack D. Bui's work include Immune Cell Function and Interaction (38 papers), Immunotherapy and Immune Responses (21 papers) and T-cell and B-cell Immunology (15 papers). Jack D. Bui is often cited by papers focused on Immune Cell Function and Interaction (38 papers), Immunotherapy and Immune Responses (21 papers) and T-cell and B-cell Immunology (15 papers). Jack D. Bui collaborates with scholars based in United States, Croatia and Slovakia. Jack D. Bui's co-authors include Robert D. Schreiber, Ravindra Uppaluri, Gavin P. Dunn, J. Michael White, Catherine Koebel, Cora D. Arthur, Kathleen C. F. Sheehan, Allen T. Bruce, Mark S. Diamond and Emilie Gross and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Jack D. Bui

77 papers receiving 4.2k citations

Hit Papers

Intratumoral immunotherapy using platelet-cloaked nanopar... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Jack D. Bui
Gang Zhou United States
Mary M. Tomayko United States
Ivan Théate Belgium
Sophia N. Karagiannis United Kingdom
Jack D. Bui
Citations per year, relative to Jack D. Bui Jack D. Bui (= 1×) peers Stefano Ugel

Countries citing papers authored by Jack D. Bui

Since Specialization
Citations

This map shows the geographic impact of Jack D. Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack D. Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack D. Bui more than expected).

Fields of papers citing papers by Jack D. Bui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack D. Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack D. Bui. The network helps show where Jack D. Bui may publish in the future.

Co-authorship network of co-authors of Jack D. Bui

This figure shows the co-authorship network connecting the top 25 collaborators of Jack D. Bui. A scholar is included among the top collaborators of Jack D. Bui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack D. Bui. Jack D. Bui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masubuchi, Takeya, Christine Caron, Jibin Zhang, et al.. (2025). Functional differences between rodent and human PD-1 linked to evolutionary divergence. Science Immunology. 10(103). eads6295–eads6295. 16 indexed citations
2.
DeFilipp, Zachariah, Hannah Choe, Yvonne A. Efebera, et al.. (2025). RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT. Blood. 146(17). 2037–2046. 1 indexed citations
3.
Chan, Alfred A., Christine Caron, Calvin K. Lee, et al.. (2025). Mammary tissue microbiome analysis in PyMT mice reveals Methylobacteria as a commensal organism with potential therapeutic applications. Translational Oncology. 59. 102451–102451.
4.
Searles, Stephen, Weishan Chen, Calvin K. Lee, et al.. (2024). MAP kinase kinase 1 (MEK1) within extracellular vesicles inhibits tumour growth by promoting anti‐tumour immunity. Journal of Extracellular Vesicles. 13(10). e12515–e12515. 1 indexed citations
5.
Zhao, Yunlong, Christine Caron, Calvin K. Lee, et al.. (2023). cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity. Immunity. 56(6). 1187–1203.e12. 43 indexed citations
6.
Caron, Christine, et al.. (2023). Dual receptor T cells mediate effective antitumor immune responses via increased recognition of tumor antigens. Journal for ImmunoTherapy of Cancer. 11(5). e006472–e006472. 6 indexed citations
7.
Xu, Xiaozheng, Jibin Zhang, Alice Sherrard, et al.. (2023). CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis. The Journal of Experimental Medicine. 220(7). 25 indexed citations
8.
Reid, Erin, Kelly A. Shimabukuro, Page C. Moore, et al.. (2022). AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma. Clinical Cancer Research. 28(12). 2646–2656. 12 indexed citations
9.
Varki, Nissi, et al.. (2020). Evaluation of IL-17D in Host Immunity to Group A Streptococcus Infection. The Journal of Immunology. 205(11). 3122–3129. 8 indexed citations
10.
Yokoyama, Yumi, Erin D. Lew, Ruth Seelige, et al.. (2019). Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor. Cancer Research. 79(8). 1996–2008. 70 indexed citations
11.
Fong, Jerry J., et al.. (2018). Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells. Proceedings of the National Academy of Sciences. 115(41). 10410–10415. 34 indexed citations
12.
Kim, Stephanie H., Kelly A. Remedios, Zhaoren He, et al.. (2018). Integrin Activation Controls Regulatory T Cell–Mediated Peripheral Tolerance. The Journal of Immunology. 200(12). 4012–4023. 30 indexed citations
13.
Seelige, Ruth, Robert Saddawi‐Konefka, Nicholas M. Adams, et al.. (2018). Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection. Scientific Reports. 8(1). 13670–13670. 27 indexed citations
14.
Strnádel, Ján, Sunkyu Choi, Ken Fujimura, et al.. (2017). eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Cancer Research. 77(8). 1997–2007. 68 indexed citations
15.
Seelige, Ruth, Stephen Searles, & Jack D. Bui. (2017). Innate sensing of cancer's non-immunologic hallmarks. Current Opinion in Immunology. 50. 1–8. 6 indexed citations
16.
Seelige, Ruth, Stephen Searles, & Jack D. Bui. (2017). Mechanisms regulating immune surveillance of cellular stress in cancer. Cellular and Molecular Life Sciences. 75(2). 225–240. 22 indexed citations
17.
Doedens, Andrew L., Mark P. Rubinstein, Emilie Gross, et al.. (2016). Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance. Cancer Immunology Research. 4(9). 799–811. 24 indexed citations
18.
O’Sullivan, Timothy E., Robert Saddawi‐Konefka, William Vermi, et al.. (2012). Cancer immunoediting by the innate immune system in the absence of adaptive immunity. The Journal of Experimental Medicine. 209(10). 1869–1882. 257 indexed citations
19.
Kreisel, Daniel, Andrew E. Gelman, Ryuji Higashikubo, et al.. (2012). Strain-Specific Variation in Murine Natural Killer Gene Complex Contributes to Differences in Immunosurveillance for Urethane-Induced Lung Cancer. Cancer Research. 72(17). 4311–4317. 22 indexed citations
20.
Judd, Nancy P., Ashley E. Winkler, Oihana Murillo, et al.. (2011). ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness. Cancer Research. 72(1). 365–374. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026